Nanotechnology enables companies to manipulate the properties of the outer shell of a capsule in order to control the release of the substance to be delivered. ‘Controlled release’ strategies are ...

BIRMINGHAM, Ala. - Type 1 diabetes, or T1D, results from the autoimmune destruction of the insulin-producing cells of the pancreas. People with T1D require exogenous insulin and suffer swings in the ...

DUBLIN--(BUSINESS WIRE)--The "Breakthrough Delivery Technologies for Flavors and Fragrances" report has been added to Research and Markets' offering. This research includes a holistic analysis of the ...

Recently, HIUV and H.B. Fuller officially entered into a strategic collaboration to deliver high-quality encapsulation solutions for the U.S. market. Under this collaboration, HIUV will provide ...